Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Brainstorm Cell Therapeutics Inc (GHDN.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
1.8905+0.0475 (+2.58%)
At close: 10:30AM CET
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
0
Operating Expense
26,119
24,539
31,684
23,001
Operating Income
-26,119
-24,539
-31,684
-23,001
Net Non Operating Interest Income Expense
670
82
-127
-252
Pretax Income
-25,449
-24,457
-31,811
-23,253
Net Income Common Stockholders
-25,449
-24,457
-31,811
-23,253
Diluted NI Available to Com Stockholders
-25,449
-24,457
-31,811
-23,253
Basic EPS
-
-0.68
-1.07
-1.06
Diluted EPS
-
-0.68
-1.07
-1.06
Basic Average Shares
-
36,182
29,848
21,906
Diluted Average Shares
-
36,182
29,848
21,906
Total Operating Income as Reported
-26,119
-24,539
-31,684
-23,001
Total Expenses
26,119
24,539
31,684
23,001
Net Income from Continuing & Discontinued Operation
-25,449
-24,457
-31,811
-23,253
Normalized Income
-25,449
-24,457
-31,811
-23,253
Net Interest Income
670
82
-127
-252
EBIT
-26,119
-24,539
-31,684
-23,001
EBITDA
-25,834
-
-
-
Reconciled Depreciation
285
260
219
164
Net Income from Continuing Operation Net Minority Interest
-25,449
-24,457
-31,811
-23,253
Normalized EBITDA
-25,834
-24,279
-31,465
-22,837
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
Advertisement
Advertisement